What are the biomarkers that can provide additional insights into cardiovascular risk? How do different pharmacological agents target specific components of non-HDL cholesterol?

Nov 1, 2022 ... A non-HDL cholesterol value includes all the atherogenic (artery-clogging) lipoprotein particles — not just LDL, but also very-low-density ... May 27, 2019 ... This study examines trends in non–HDL-C and LDL-C levels in a free living population of ASCVD subjects between 1999 and 2016. Highlights. •. Non-HDL-C is a consistent and reliable residual risk predictor of ASCVD and all non-HDL-C contributing lipoproteins independently promote ASCVD. 2022;22(6):1025-1032 1025www.bjbms.orgINTRODUCTIONAbnormalities in serum lipids, including elevated blood low-density lipoprotein cholesterol (LDL-C), ... Objective: The objective of this study was to evaluate the association between non-HDL-C and cognitive function among American elders. Non-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes: The Strong Heart Study. Study results indicate this cholesterol index would ... ... cholesterol (non-HDL-C) as markers of cardiovascular risk. OBJECTIVE: We ... RESULTS: Plasma triglyceride and non-HDL-C levels were highest in the ... Jun 8, 2016 ... ... non-HDL cholesterol levels (< 100 mg/dL). After PCI, higher levels of high-sensitivity C-reactive protein (hsCRP) were found in the blood ... Mar 28, 2022 ... Non-HDL-C has been associated with the prognosis and long-term prognosis of acute myocardial infarction, but the association between ... Dec 22, 2022 ... High Apo B/low non-HDL-C was associated with a higher all-cause risk than low Apo B/high non-HDL-C. In conclusion, Johannesen, et al . [1] ...